Modulation of intravariceal pressure with pentoxifylline: a possible new approach in the treatment of portal hypertension.
OBJECTIVE
In this study the effect of the hemorheological agent pentoxifylline on the pressure of esophageal varices was investigated in portal hypertensive cirrhotic patients.


METHODS
Intravariceal pressure was measured endoscopically using the direct puncture technique in 20 patients. Measurements were obtained under baseline conditions and 30 min after double-blind administration of pentoxifylline (1.4 mg/kg BW, n = 10 patients) or an identical volume of NaCl 0.9% solution (n = 10 patients).


RESULTS
Under baseline conditions, intravariceal pressure was similar in pentoxifylline and placebo groups (17.3+/-5.5 mm Hg vs 18.8+/-4.6 mm Hg, respectively; p = N.S.). Placebo administration had no significant effect on intravariceal pressure (18.8+/-4.6 mm Hg vs 18.3+/-4.1 mm Hg; p = N.S.). In contrast, pentoxifylline caused a highly significant reduction of intravariceal pressure, (from 17.3+/-5.5 mm Hg to 11.4+/-5.9 mm Hg; p = 0.0001), the overall mean reduction being 36.1+/-14.1% mm Hg.


CONCLUSIONS
We concluded that pentoxifylline, by reducing blood flow viscosity, caused a significant decrease in variceal pressure in patients suffering from portal hypertension.
Eleftheriadis
E
E
Department of Surgery, University of Thessaloniki, Greece.
Kotzampassi
K
K
Koufogiannis
D
D
D004311:Double-Blind Method; D004932:Esophageal and Gastric Varices / Q000188:drug therapy* / Q000503:physiopathology*; D005260:Female; D006401:Hematologic Agents / Q000627:therapeutic use*; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000627:therapeutic use*; D011312:Pressure
D006401:Hematologic Agents; D010431:Pentoxifylline